# Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

> **NCT01026467** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 45 (actual)

## Conditions studied

- Recurrent Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** carboplatin
- **OTHER:** questionnaire administration

## Key facts

- **NCT ID:** NCT01026467
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026467, "Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01026467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*